Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features
- PMID: 30561534
- DOI: 10.1093/brain/awy297
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features
Abstract
Kufs disease is the major adult form of neuronal ceroid lipofuscinosis, but is rare and difficult to diagnose. Diagnosis was traditionally dependent on the demonstration of characteristic storage material, but distinction from normal age-related accumulation of lipofuscin can be challenging. Mutation of CLN6 has emerged as the most important cause of recessive Kufs disease but, remarkably, is also responsible for variant late infantile ceroid lipofuscinosis. Here we provide a detailed description of Kufs disease due to CLN6 pathogenic variants. We studied 20 cases of Kufs disease with CLN6 pathogenic variants from 13 unrelated families. Mean age of onset was 28 years (range 12-51) with bimodal peaks in teenage and early adult life. The typical presentation was of progressive myoclonus epilepsy with debilitating myoclonic seizures and relatively infrequent tonic-clonic seizures. Patients became wheelchair-bound with a mean 12 years post-onset. Ataxia was the most prominent motor feature. Dementia appeared to be an invariable accompaniment, although it could take a number of years to manifest and occasionally cognitive impairment preceded myoclonic seizures. Patients were usually highly photosensitive on EEG. MRI showed progressive cerebral and cerebellar atrophy. The median survival time was 26 years from disease onset. Ultrastructural examination of the pathology revealed fingerprint profiles as the characteristic inclusions, but they were not reliably seen in tissues other than brain. Curvilinear profiles, which are seen in the late infantile form, were not a feature. Of the 13 unrelated families we observed homozygous CLN6 pathogenic variants in four and compound heterozygous variants in nine. Compared to the variant late infantile form, there was a lower proportion of variants that predicted protein truncation. Certain heterozygous missense variants in the same amino acid position were found in both variant late infantile and Kufs disease. There was a predominance of cases from Italy and surrounding regions; this was partially explained by the discovery of three founder pathogenic variants. Clinical distinction of type A (progressive myoclonus epilepsy) and type B (dementia with motor disturbance) Kufs disease was supported by molecular diagnoses. Type A is usually caused by recessive pathogenic variants in CLN6 or dominant variants in DNAJC5. Type B Kufs is usually associated with recessive CTSF pathogenic variants. The diagnosis of Kufs remains challenging but, with the availability of genetic diagnosis, this will largely supersede the use of diagnostic biopsies, particularly as biopsies of peripheral tissues has unsatisfactory sensitivity and specificity.
Comment in
-
Kufs or not Kufs: challenging diagnostics of a rare adult-onset neurodegenerative disease.Brain. 2019 Jan 1;142(1):2-5. doi: 10.1093/brain/awy312. Brain. 2019. PMID: 30596907 No abstract available.
Similar articles
-
Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6.Am J Hum Genet. 2011 May 13;88(5):566-73. doi: 10.1016/j.ajhg.2011.04.004. Epub 2011 May 5. Am J Hum Genet. 2011. PMID: 21549341 Free PMC article.
-
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.Hum Mol Genet. 2013 Apr 1;22(7):1417-23. doi: 10.1093/hmg/dds558. Epub 2013 Jan 7. Hum Mol Genet. 2013. PMID: 23297359 Free PMC article.
-
CLN6-related continuum phenotype caused by aberrant splicing.Epilepsia Open. 2025 Feb;10(1):348-354. doi: 10.1002/epi4.13119. Epub 2024 Dec 24. Epilepsia Open. 2025. PMID: 39718800 Free PMC article.
-
Kufs disease: clinical features and forms.Am J Med Genet Suppl. 1988;5:105-9. doi: 10.1002/ajmg.1320310614. Am J Med Genet Suppl. 1988. PMID: 3146309 Review.
-
Kufs' disease: a critical reappraisal.Brain. 1988 Feb;111 ( Pt 1):27-62. doi: 10.1093/brain/111.1.27. Brain. 1988. PMID: 3284607 Review.
Cited by
-
Moyamoya and progressive myoclonic epilepsy secondary to CLN6 bi-allelic mutations - A previously unreported association.Epilepsy Behav Rep. 2020 Aug 31;14:100389. doi: 10.1016/j.ebr.2020.100389. eCollection 2020. Epilepsy Behav Rep. 2020. PMID: 33024953 Free PMC article.
-
Nosology and Phenomenology of Psychosis in Movement Disorders.Mov Disord Clin Pract. 2020 Jan 7;7(2):140-153. doi: 10.1002/mdc3.12882. eCollection 2020 Feb. Mov Disord Clin Pract. 2020. PMID: 32071931 Free PMC article. Review.
-
Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.Mol Cell Biol. 2020 Sep 14;40(19):e00262-20. doi: 10.1128/MCB.00262-20. Print 2020 Sep 14. Mol Cell Biol. 2020. PMID: 32690545 Free PMC article. Review.
-
A novel homozygous CLN6 Tyr142Cys variant in a nonconsanguineous family with Kufs disease.Neurol Sci. 2024 Sep;45(9):4597-4600. doi: 10.1007/s10072-024-07579-5. Epub 2024 May 21. Neurol Sci. 2024. PMID: 38771523
-
Converging links between adult-onset neurodegenerative Alzheimer's disease and early life neurodegenerative neuronal ceroid lipofuscinosis?Neural Regen Res. 2023 Jul;18(7):1463-1471. doi: 10.4103/1673-5374.361544. Neural Regen Res. 2023. PMID: 36571343 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases